These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2671560)

  • 1. Combined regimens of one year duration in the treatment of multibacillary leprosy--II. Combined regimens with rifampicin administered during 6 months.
    Pattyn SR; Groenen G; Janssens L; Deverchin J; Ghys P
    Lepr Rev; 1989 Jun; 60(2):118-23. PubMed ID: 2671560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
    Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
    Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory treatment of multibacillary leprosy with a regimen of 8 months duration.
    Pattyn SR; Bourland J; Kazeze
    Lepr Rev; 1992 Mar; 63(1):36-40. PubMed ID: 1569814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences].
    Millan J; Roux G; Loko S; Naudin JC; Boucher P; Bodian M; Camara M; Moreira-Diop T; Grosset J
    Acta Leprol; 1986; 4(4):427-44. PubMed ID: 3296613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
    Pattyn S; Grillone S
    Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity of the combination of rifampin-ethionamide in the treatment of multibacillary leprosy.
    Pattyn SR; Janssens L; Bourland J; Saylan T; Davies EM; Grillone S; Feracci C
    Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):1-6. PubMed ID: 6368424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of two regimens of combined chemotherapy of one year duration in multibacillary leprosy. Results after four and five years' follow-up.
    Pattyn SR; André PS; Ferracci C; Baquillon G
    Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):297-303. PubMed ID: 6541198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of multibacillary leprosy with a regimen of 13 weeks duration.
    Pattyn SR; Groenen G; Janssens L; Kuykens L; Mputu LB
    Lepr Rev; 1992 Mar; 63(1):41-6. PubMed ID: 1569815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of drug regimen in lepromatous leprosy--II.
    Ramu G; Sreevatsa
    Lepr India; 1983 Apr; 55(2):200-8. PubMed ID: 6195452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of combined treatments comprising 6 months' administration of rifampicin in multibacillary leprosy].
    Pattyn SR; Husser JA; Saint-André P
    Acta Leprol; 1986; 4(4):445-6. PubMed ID: 3296614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide.
    Winsley BE; McDougall AC; Brown KE
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):592-4. PubMed ID: 6686974
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens.
    Fajardo TT; Villahermosa L; Pardillo FE; Abalos RM; Burgos J; Dela Cruz E; Gelber RH
    Am J Trop Med Hyg; 2009 Aug; 81(2):330-4. PubMed ID: 19635893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new plan in the campaign against leprosy in Anjouan. Preliminary results].
    Grillone S; Pattyn SR
    Acta Leprol; 1986; 4(4):453-60. PubMed ID: 3296616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A trial of polychemotherapy of leprosy in the Dakar region. Initial observations on the acceptability of the protocols used].
    Millan J; Bodian M; Naudin JC; Diouf B; Boucher P; Ndoye B; Grosset J
    Acta Leprol; 1986; 4(1):19-35. PubMed ID: 3526792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
    Gallo ME; Alvim MF; Nery JA; Albuquerque EC; Sarno EN
    Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two multidrug regimens in multibacillary leprosy.
    Jadhav VH; Patki AH; Mehta JM
    Indian J Lepr; 1992; 64(4):501-4. PubMed ID: 1308526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of MDT in multibacillary leprosy.
    Jesudasan K; Vijayakumaran P; Manimozhi N; Rao PS; Samuel P
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):128-32. PubMed ID: 8690970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.